UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MRNA — Moderna, Inc.
CIK 861177
NEW YORK, NY
Position in MRNA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$82,325,155
+$35,460,743 QoQ
Shares Held
1,620,574
+2.0% QoQ
Ownership
0.408%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52.731994959810535.ToString("F0")%
Shared 0.ToString("F0")%
None 47.268005040189465.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. MRNA ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,325,155 | 1,620,574 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $46,864,412 | 1,589,163 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $50,651,799 | 1,960,968 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $83,410,828 | 3,023,227 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $101,981,634 | 3,597,236 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $149,104,460 | 3,585,966 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $260,022,958 | 3,890,812 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $459,680,413 | 3,870,993 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $391,399,457 | 3,673,043 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $296,871,173 | 2,985,130 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $250,279,101 | 2,423,072 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,058,976 | 1,465,506 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $225,072,406 | 1,465,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $256,556,090 | 1,428,327 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $147,179,384 | 1,244,646 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $173,133,764 | 1,211,997 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $208,915,889 | 1,212,794 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $346,683,965 | 1,365,005 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $503,885,648 | 1,309,270 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $281,375,387 | 1,197,444 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $122,302,583 | 933,964 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $97,707,861 | 935,272 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $57,055,344 | 806,436 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $46,326,549 | 721,485 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,243,347 | 308,626 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||